GlassScriptPhysician profile
Michael Joseph Whalen
NPI 1164675245
$17,306.02
in general payments reported to CMS, 2019-2025
34 companies · $10K in 2025
The $10K reported for 2025 was more than what 94% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $896 · 2020: $228 · 2021: $191 · 2022: $169 · 2023: $1,738 · 2024: $3,952 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Consulting Fee: $3,482 · Food and Beverage: $2,656 · Travel and Lodging: $2,527 · Honoraria: $2,400 · Education: $750 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Consulting Fee | $3,481.50 |
| Food and Beverage | $2,655.77 |
| Travel and Lodging | $2,526.61 |
| Honoraria | $2,400.00 |
| Education | $750.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $4,142.65 | 2022-2025 | |
| Ferring Pharmaceuticals INC. | $3,776.97 | 2025 | Adstiladrin |
| Intuitive Surgical, INC. | $2,646.34 | 2023-2025 | Da Vinci Surgical System |
| Urogen Pharma, INC. | $2,639.52 | 2021-2025 | |
| Angiodynamics, INC. | $1,330.55 | 2023 | Nanoknife |
| Janssen Biotech, INC. | $307.96 | 2019-2025 | Erleada |
| Agiliti Surgical, INC. | $300.44 | 2024-2025 | Sonablate Hifu, Koelis Trinity Fusion Biopsy System |
| Photocure INC | $282.62 | 2019 | |
| Dendreon Pharmaceuticals LLC | $171.56 | 2019-2020 | |
| Immunitybio, INC. | $162.08 | 2025 | |
| Acera Surgical, INC. | $160.86 | 2025 | Restrata Wound Matrix |
| Profound Medical Corp. | $134.41 | 2025 | Tulsa-Pro |
| Tempus Ai, INC | $133.39 | 2024-2025 | Xt Cdx |
| Astellas Pharma US INC | $125.97 | 2019-2020 | |
| Blue Earth Diagnostics | $121.35 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $120.65 | 2025 | Exparel |
| Ethicon US, LLC | $116.17 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $98.74 | 2024 | |
| Galvanize Therapeutics, INC | $69.12 | 2025 | Aliya System |
| Myovant Sciences INC. | $61.15 | 2021-2022 | |
| Boston Scientific Corporation | $46.47 | 2024-2025 | Spaceoar Vue System - 10ml, Lithovue |
| Sumitomo Pharma America, INC. | $46.41 | 2023 | Orgovyx |
| Olympus America INC. | $37.66 | 2023-2024 | Uretero-Reno Videoscope, Itind System |
| Lantheus Medical Imaging, INC. | $36.30 | 2024 | |
| Abbvie INC. | $34.96 | 2024 | |
| Syndax Pharmaceuticals, INC. | $32.39 | 2025 | |
| Tolmar, INC. | $27.87 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $24.63 | 2022 | |
| Becton, Dickinson and Company | $23.86 | 2019 | |
| Laborie Medical Technologies Corp. | $23.04 | 2025 | |
| Palette Life Sciences, INC. | $20.50 | 2022 | |
| Janssen Pharmaceuticals, INC | $20.14 | 2019 | |
| Endo Pharmaceuticals INC. | $17.53 | 2019 | |
| Mission Pharmacal Company | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Whalen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.